Contributed Commentary by Barry Krakow, MD October 22, 2026 | Chronic insomnia (difficulty falling asleep or staying asleep) is a devilishly tricky condition to treat, and for millions cures remain...
Read MoreBy Allison Proffitt September 8, 2026 | LinusBio is delving into the exposome with Traced, a new hair testing tool designed to give consumers a month-long view of their exposure...
Read MoreBy Deborah Borfitz For decades now, doctors have been referring people suspected of having obstructive sleep apnea to a specialized medical facility for a polysomnogram (PSG). The gold-standard overnight test...
Read MoreBy Irene Yeh As incretin-based medications, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide (GIP) drugs, become increasingly common in obesity and weight management, questions remain about their...
Read MoreBy Deborah Borfitz Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused...
Read MoreBy Irene Yeh Eating a healthy diet during pregnancy may come with an unexpected tradeoff: some foods recommended for good nutrition can also be sources of environmental chemical exposure. The...
Read MoreBy Irene Yeh Originally developed to treat type 2 diabetes and later for obesity management, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are rapidly expanding into other areas of treatment. Researchers...
Read MoreBy Deborah Borfitz The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit...
Read More